These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Salvia-Nelumbinis naturalis improves lipid metabolism of NAFLD by regulating the SIRT1/AMPK signaling pathway. Liu Y, Li Y, Wang J, Yang L, Yu X, Huang P, Song H, Zheng P. BMC Complement Med Ther; 2022 Aug 09; 22(1):213. PubMed ID: 35945571 [Abstract] [Full Text] [Related]
3. Atractylenolide III ameliorates Non-Alcoholic Fatty Liver Disease by activating Hepatic Adiponectin Receptor 1-Mediated AMPK Pathway. Li Q, Tan JX, He Y, Bai F, Li SW, Hou YW, Ji LS, Gao YT, Zhang X, Zhou ZH, Yu Z, Fang M, Gao YQ, Li M. Int J Biol Sci; 2022 Aug 09; 18(4):1594-1611. PubMed ID: 35280674 [Abstract] [Full Text] [Related]
7. Fisetin Protects Against Hepatic Steatosis Through Regulation of the Sirt1/AMPK and Fatty Acid β-Oxidation Signaling Pathway in High-Fat Diet-Induced Obese Mice. Liou CJ, Wei CH, Chen YL, Cheng CY, Wang CL, Huang WC. Cell Physiol Biochem; 2018 Aug 09; 49(5):1870-1884. PubMed ID: 30235452 [Abstract] [Full Text] [Related]
8. Patchouli alcohol ameliorates skeletal muscle insulin resistance and NAFLD via AMPK/SIRT1-mediated suppression of inflammation. Pyun DH, Kim TJ, Park SY, Lee HJ, Abd El-Aty AM, Jeong JH, Jung TW. Mol Cell Endocrinol; 2021 Dec 01; 538():111464. PubMed ID: 34601002 [Abstract] [Full Text] [Related]
9. Protective Effects of Licochalcone A Ameliorates Obesity and Non-Alcoholic Fatty Liver Disease Via Promotion of the Sirt-1/AMPK Pathway in Mice Fed a High-Fat Diet. Liou CJ, Lee YK, Ting NC, Chen YL, Shen SC, Wu SJ, Huang WC. Cells; 2019 May 11; 8(5):. PubMed ID: 31083505 [Abstract] [Full Text] [Related]
10. Kangtaizhi Granule Alleviated Nonalcoholic Fatty Liver Disease in High-Fat Diet-Fed Rats and HepG2 Cells via AMPK/mTOR Signaling Pathway. Zhang J, Du H, Shen M, Zhao Z, Ye X. J Immunol Res; 2020 May 11; 2020():3413186. PubMed ID: 32884949 [Abstract] [Full Text] [Related]
11. Dioscin alleviates non-alcoholic fatty liver disease through adjusting lipid metabolism via SIRT1/AMPK signaling pathway. Yao H, Tao X, Xu L, Qi Y, Yin L, Han X, Xu Y, Zheng L, Peng J. Pharmacol Res; 2018 May 11; 131():51-60. PubMed ID: 29574225 [Abstract] [Full Text] [Related]
12. Kaempferol attenuates nonalcoholic fatty liver disease in type 2 diabetic mice via the Sirt1/AMPK signaling pathway. Li N, Yin L, Shang J, Liang M, Liu Z, Yang H, Qiang G, Du G, Yang X. Biomed Pharmacother; 2023 Sep 11; 165():115113. PubMed ID: 37418974 [Abstract] [Full Text] [Related]
15. γ-Mangostin Ameliorates Free Fatty Acid-Induced Lipid Accumulation via the SIRT1/LKB1/AMPK Pathway in HepG2 and L02 Cells. Gu L, Cai N, Lyu Y, Yao L, Wang F, Xu H, Hu Z, Li H, Xu X. J Agric Food Chem; 2019 Dec 18; 67(50):13929-13938. PubMed ID: 31674780 [Abstract] [Full Text] [Related]
16. Cardiotrophin-1 eliminates hepatic steatosis in obese mice by mechanisms involving AMPK activation. Castaño D, Larequi E, Belza I, Astudillo AM, Martínez-Ansó E, Balsinde J, Argemi J, Aragon T, Moreno-Aliaga MJ, Muntane J, Prieto J, Bustos M. J Hepatol; 2014 May 18; 60(5):1017-25. PubMed ID: 24362075 [Abstract] [Full Text] [Related]
18. Asperuloside alleviates lipid accumulation and inflammation in HFD-induced NAFLD via AMPK signaling pathway and NLRP3 inflammasome. Shen Q, Chen Y, Shi J, Pei C, Chen S, Huang S, Li W, Shi X, Liang J, Hou S. Eur J Pharmacol; 2023 Mar 05; 942():175504. PubMed ID: 36641101 [Abstract] [Full Text] [Related]
19. Pterostilbene and Its Derivative 3'-Hydroxypterostilbene Ameliorated Nonalcoholic Fatty Liver Disease Through Synergistic Modulation of the Gut Microbiota and SIRT1/AMPK Signaling Pathway. Tsai HY, Shih YY, Yeh YT, Huang CH, Liao CA, Hu CY, Nagabhushanam K, Ho CT, Chen YK. J Agric Food Chem; 2022 Apr 27; 70(16):4966-4980. PubMed ID: 35416649 [Abstract] [Full Text] [Related]